https://www.selleckchem.com/pr....oducts/iberdomide.ht
The paclitaxel-loaded nanofibrous membranes provided sustained drug release and site-specific treatment by directly targeting and changing the tumor microenvironment, resulting in low systemic toxicity and a significant improvement in the therapeutic effect and safety compared with conventional chemotherapy. Thus, metronomic chemotherapy with paclitaxel-loaded nanofibrous membranes offers a promising strategy for the treatment of TNBC.A chondrosarcoma is a common tumor of the soft tissue and bone that has a high propensity to metasta
Curtir
Comentario
Compartilhar
